Centenary Institute researcher Dr Claudio Counoupas has featured as a case study in a 2020 AAMRI (Association of Australian Medical Research Institutes) Budget Submission to Federal Government.
The Submission highlights the need for increased support of the next generation of outstanding Australian research talent–particularly in the face of funding challenges caused by the COVID-19 economic downturn.
Four of Australia’s leading early to mid-career researchers were profiled in the Submission.
Dr Counoupas is co-leader on a collaborative Centenary Institute and University of Sydney project in which he is focused on repurposing an existing tuberculosis vaccine for use against COVID-19.
View information on the AAMRI Submission here.
View the actual Submission here.
Professor John Rasko AO has led a world-first clinical trial into engineered stem cell treatment use, treating 15 patients with steroid resistant acute graft-versus-host disease.
Centenary Institute research has discovered that the lack of an enzyme in the liver called sphingosine kinase 2 results in pronounced insulin resistance and glucose intolerance, both symptoms of early stage type 2 diabetes.
Research led by the Centenary Institute has shown that a healthy weight and coffee consumption may help lower the risk of high-risk drinkers developing alcohol-induced cirrhosis.